INTS vs SO
Intensity Therapeutics, Inc. Common stock (INTS) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported SO revenue for 2016-09-30 was $6.26B. Net income was $1.17B. Revenue was down 25.9% from 2016-06-30 to 2016-09-30. SO currently screens at market cap $101.55B and trailing P/E 22.1.
INTS currently screens at market cap $7.7M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the INTS and SO stock pages for the full models.
Not investment advice.